Poly(I:C) promotes the production of IL-17A by murine CD1d-driven invariant NKT cells in airway inflammation.

Background IL-17A is associated with different asthma phenotypes as virus-associated or steroid-resistant asthma. Invariant natural killer T (iNKT) cells play an important role in the pathogenesis of asthma. The aim of the study was to evaluate the activity of polyinosinic–polycytidylic acid [poly(I:C)] on IL-17A production by CD1d-activated iNKT cells. Methods We analysed the in vitro effect of poly(I:C) on the release of IL-17A by spleen and lung CD1d-activated iNKT cells with α-galactosylceramide (α-GalCer). Its activity was also investigated in an α-GalCer-induced murine models, including lung inflammation. The inhibition of IL-17A by Toll-like receptor (TLR) 7 agonists in the same in vitro and in vivo models has been analysed. Results Poly(I:C) upregulated the in vitro IL-17A production by CD1d-activated NK1.1− CD4− iNKT subset, without modifying type 1 and type 2 cytokines. The two stimuli selectively upregulated IL-17A serum levels in vivo. Their intratracheal administration resulted in increased airway hyper-reactivity (AHR), neutrophilia in bronchoalveolar lavage and airway inflammation, which were inhibited by anti-IL-17A antibody. Poly(I:C) effects were attributable to IL1β and IL-23 release from dendritic cells, as showed by inhibition with neutralizing antibodies. TLR7 agonists inhibited the IL-17A production by poly(I:C) plus α-GalCer in the same models. Such effect was associated with the increased production by DC of IL-17A-inhibiting cytokines and the dampening of IL-1β and IL-23. Conclusions Synthetic dsRNA selectively expand a CD1d-driven IL-17A-producing iNKT cell subset, thus explaining the worsening of airway inflammation by some viral infections. TLR3- and TLR7-triggering viral sequences can exert variable and opposite effects on adaptive immune response.

[1]  D. Chaussabel,et al.  Herpes simplex virus encephalitis in a patient with complete TLR3 deficiency: TLR3 is otherwise redundant in protective immunity , 2011, The Journal of experimental medicine.

[2]  P. Rogers,et al.  Invariant NKT cells are required for airway inflammation induced by environmental antigens , 2011, The Journal of experimental medicine.

[3]  G. Besra,et al.  Innate and cytokine-driven signals, rather than microbial antigens, dominate in natural killer T cell activation during microbial infection , 2011, The Journal of experimental medicine.

[4]  S. Su,et al.  Toll-like receptor 3 ligand polyinosinic:polycytidylic acid enhances autoimmune disease in a retinal autoimmunity model. , 2011, International immunopharmacology.

[5]  U. Švajger,et al.  Mechanism of Endosomal TLR Inhibition by Antimalarial Drugs and Imidazoquinolines , 2011, The Journal of Immunology.

[6]  F. Annunziato,et al.  The TLR7 Ligand 9-Benzyl-2-Butoxy-8-Hydroxy Adenine Inhibits IL-17 Response by Eliciting IL-10 and IL-10–Inducing Cytokines , 2011, The Journal of Immunology.

[7]  A. Fryer,et al.  Toll-like receptor 7 agonists are potent and rapid bronchodilators in guinea pigs. , 2011, The Journal of allergy and clinical immunology.

[8]  Y. Gho,et al.  A viral PAMP double‐stranded RNA induces allergen‐specific Th17 cell response in the airways which is dependent on VEGF and IL‐6 , 2010, Allergy.

[9]  S. S. Jensen,et al.  Differential induction of inflammatory cytokines by dendritic cells treated with novel TLR-agonist and cytokine based cocktails: targeting dendritic cells in autoimmunity , 2010, Journal of Inflammation.

[10]  V. Aidinis,et al.  Toll-like receptor 7-triggered immune response in the lung mediates acute and long-lasting suppression of experimental asthma. , 2010, American journal of respiratory and critical care medicine.

[11]  T. Wynn,et al.  Bleomycin and IL-1β–mediated pulmonary fibrosis is IL-17A dependent , 2010, The Journal of experimental medicine.

[12]  Jiuhong Kang,et al.  MicroRNA miR-326 regulates TH-17 differentiation and is associated with the pathogenesis of multiple sclerosis , 2009, Nature Immunology.

[13]  S. Paludan,et al.  TLR3 Ligand Polyinosinic:Polycytidylic Acid Induces IL-17A and IL-21 Synthesis in Human Th Cells1 , 2009, The Journal of Immunology.

[14]  Kai-ping Yan,et al.  iNKT cell development is orchestrated by different branches of TGF-β signaling , 2009, The Journal of experimental medicine.

[15]  D. Bani,et al.  Modified Adenine (9-Benzyl-2-Butoxy-8-Hydroxyadenine) Redirects Th2-Mediated Murine Lung Inflammation by Triggering TLR71 , 2009, The Journal of Immunology.

[16]  T. Chiba,et al.  Human TSLP and TLR3 ligands promote differentiation of Th17 cells with a central memory phenotype under Th2‐polarizing conditions , 2008, Clinical and experimental allergy : journal of the British Society for Allergy and Clinical Immunology.

[17]  J. Alcorn,et al.  TH17 Cells Mediate Steroid-Resistant Airway Inflammation and Airway Hyperresponsiveness in Mice1 , 2008, The Journal of Immunology.

[18]  M. Smyth,et al.  Diverse cytokine production by NKT cell subsets and identification of an IL-17–producing CD4−NK1.1− NKT cell population , 2008, Proceedings of the National Academy of Sciences.

[19]  M. Nyegaard,et al.  Association analysis identifies TLR7 and TLR8 as novel risk genes in asthma and related disorders , 2008, Thorax.

[20]  L. Cosmi,et al.  Human interleukin 17–producing cells originate from a CD161+CD4+ T cell precursor , 2008, The Journal of experimental medicine.

[21]  Angeliki Xagorari,et al.  Toll-Like Receptors and Viruses: Induction of Innate Antiviral Immune Responses , 2008, The open microbiology journal.

[22]  A. Rachitskaya,et al.  Cutting Edge: NKT Cells Constitutively Express IL-23 Receptor and RORγt and Rapidly Produce IL-17 upon Receptor Ligation in an IL-6-Independent Fashion1 , 2008, The Journal of Immunology.

[23]  D. Radzioch,et al.  Chronic asthma-induced airway remodeling is prevented by toll-like receptor-7/8 ligand S28463. , 2007, American journal of respiratory and critical care medicine.

[24]  Yasushi Saito,et al.  T-bet inhibits both TH2 cell-mediated eosinophil recruitment and TH17 cell-mediated neutrophil recruitment into the airways. , 2007, The Journal of allergy and clinical immunology.

[25]  P. Scholtes,et al.  Isolation of CD4+ T cells from murine lungs: a method to analyze ongoing immune responses in the lung , 2006, Nature Protocols.

[26]  L. Cosmi,et al.  Redirection of allergen-specific TH2 responses by a modified adenine through Toll-like receptor 7 interaction and IL-12/IFN release. , 2006, The Journal of allergy and clinical immunology.

[27]  G. Berry,et al.  Glycolipid activation of invariant T cell receptor+ NK T cells is sufficient to induce airway hyperreactivity independent of conventional CD4+ T cells. , 2006, Proceedings of the National Academy of Sciences of the United States of America.

[28]  Sergio Romagnani,et al.  Role for Interferon‐γ in the Immunomodulatory Activity of Human Bone Marrow Mesenchymal Stem Cells , 2006 .

[29]  S. Johnston,et al.  Asthmatic bronchial epithelial cells have a deficient innate immune response to infection with rhinovirus , 2005, The Journal of experimental medicine.

[30]  D. Umetsu,et al.  Essential role of NKT cells producing IL-4 and IL-13 in the development of allergen-induced airway hyperreactivity , 2003, Nature Medicine.

[31]  Q. Hamid,et al.  IL-17 is increased in asthmatic airways and induces human bronchial fibroblasts to produce cytokines. , 2001, The Journal of allergy and clinical immunology.

[32]  Hyun-Jeong Ko,et al.  A distinct subset of natural killer T cells produces IL-17, contributing to airway infiltration of neutrophils but not to airway hyperreactivity. , 2008, Cellular immunology.

[33]  H. Hoymann,et al.  Invasive and noninvasive lung function measurements in rodents. , 2007, Journal of pharmacological and toxicological methods.

[34]  J. Kolls,et al.  Interleukin-17: an emerging role in lung inflammation. , 2003, American journal of respiratory cell and molecular biology.

[35]  E. Maggi.  The TH1/TH2 paradigm in allergy. , 1998, Immunotechnology : an international journal of immunological engineering.